- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 276
Doctor on Demand prescribes $75m series D
General Atlantic led a $75m series D round for Doctor on Demand, a virtual care provider with shareholders including GV, Qualcomm Ventures and Dignify Health.
Jul 10, 2020LumiThera sees light in $14m series C
Nikon was among the investors that helped the eye disease treatment developer close a round that pushed its overall funding to $24m.
Jul 9, 2020Truepill fulfils $25m series B
Optum Ventures helped the prescription fulfilment platform push its total funding to more than $39m, with the cash to fund product development.
Jul 9, 2020Daily deal net: July 9, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jul 9, 2020WBA moves into VillageMD with $250m
VillageMD is set to receive a total of $1bn in equity and convertible debt financing from Walgreens Boots Alliance over the next three years, giving the corporate a 30% stake.
Jul 9, 2020Linge to leap from Chalmers to Lipidor
Chalmers Ventures head of startups Stina Linge will leave on September 2 to head up Lipidor's animal health products unit Emollivet.
Jul 9, 2020VarmX arms itself with $36.2m series B
Lundbeckfonden Ventures took a board seat at Leiden spinout VarmX as part of a round that will fund development of a treatment for spontaneous bleeding.
Jul 9, 2020VelosBio sells investors on $137m series B
The cancer therapy developer boosted its overall funding to more than $200m in a round that included series A backer Takeda Ventures.
Jul 9, 2020VarmX arms itself with series B cash
Lundbeckfonden Ventures took a board seat at VarmX as part of a $36.2m round that will fund development of a treatment for spontaneous bleeding.
Jul 9, 2020AlloVir approaches public markets
Baylor College spinout AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.
Jul 8, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


